WO1998023297A3 - Compositions particulaires - Google Patents
Compositions particulaires Download PDFInfo
- Publication number
- WO1998023297A3 WO1998023297A3 PCT/GB1997/003283 GB9703283W WO9823297A3 WO 1998023297 A3 WO1998023297 A3 WO 1998023297A3 GB 9703283 W GB9703283 W GB 9703283W WO 9823297 A3 WO9823297 A3 WO 9823297A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- vesicles
- particulate compositions
- aqueous medium
- contrast agent
- ray contrast
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
- A61K49/0461—Dispersions, colloids, emulsions or suspensions
- A61K49/0466—Liposomes, lipoprotein vesicles, e.g. HDL or LDL lipoproteins, phospholipidic or polymeric micelles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU51293/98A AU5129398A (en) | 1996-11-29 | 1997-11-28 | Particulate compositions |
JP52444098A JP2001504837A (ja) | 1996-11-29 | 1997-11-28 | 粒状組成物 |
EP97945974A EP1009445A2 (fr) | 1996-11-29 | 1997-11-28 | Compositions particulaires |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9624918.0 | 1996-11-29 | ||
GBGB9624918.0A GB9624918D0 (en) | 1996-11-29 | 1996-11-29 | Particulate components |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1998023297A2 WO1998023297A2 (fr) | 1998-06-04 |
WO1998023297A3 true WO1998023297A3 (fr) | 1998-07-16 |
Family
ID=10803721
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB1997/003283 WO1998023297A2 (fr) | 1996-11-29 | 1997-11-28 | Compositions particulaires |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1009445A2 (fr) |
JP (1) | JP2001504837A (fr) |
AU (1) | AU5129398A (fr) |
GB (1) | GB9624918D0 (fr) |
WO (1) | WO1998023297A2 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO20004795D0 (no) | 2000-09-26 | 2000-09-26 | Nycomed Imaging As | Peptidbaserte forbindelser |
DE602007012693D1 (de) * | 2006-05-26 | 2011-04-07 | Baxter Healthcare Sa | Injizierbare fibrin-zusammensetzung zur knochenverstärkung |
WO2011117236A1 (fr) * | 2010-03-23 | 2011-09-29 | Ge Healthcare As | Préparation d'une composition diagnostique radiographique stabilisée |
EP2606912A1 (fr) * | 2011-12-23 | 2013-06-26 | Central Medical Service Co., Ltd. | Composition de substance de contraste avec effet d'amélioration de contraste comprenant un agent hautement concentré |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989011272A1 (fr) * | 1988-05-20 | 1989-11-30 | The Liposome Company, Inc. | Complexe agent actif:lipide a rapport eleve |
WO1992010166A1 (fr) * | 1990-12-11 | 1992-06-25 | Sintetica S.A. | Procede de production de liposomes a capacite accrue de piegeage des substances etrangeres a encapsuler |
WO1995026205A1 (fr) * | 1994-03-28 | 1995-10-05 | Nycomed Imaging A/S | Liposomes |
WO1995026185A1 (fr) * | 1994-03-28 | 1995-10-05 | Daiichi Pharmaceutical Co., Ltd. | Liposome a capacite de retention accrue |
WO1996024381A2 (fr) * | 1995-02-09 | 1996-08-15 | Schering Aktiengesellschaft | Liposomes contenant des agents de contraste pour l'imagerie relative au pool sanguin intracardiaque |
WO1996025955A1 (fr) * | 1995-02-24 | 1996-08-29 | Bracco Research S.A. | Suspensions de liposomes utilisees comme produit de contraste de visualisation du pool sanguin intracardiaque |
-
1996
- 1996-11-29 GB GBGB9624918.0A patent/GB9624918D0/en active Pending
-
1997
- 1997-11-28 EP EP97945974A patent/EP1009445A2/fr not_active Withdrawn
- 1997-11-28 JP JP52444098A patent/JP2001504837A/ja active Pending
- 1997-11-28 AU AU51293/98A patent/AU5129398A/en not_active Abandoned
- 1997-11-28 WO PCT/GB1997/003283 patent/WO1998023297A2/fr not_active Application Discontinuation
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989011272A1 (fr) * | 1988-05-20 | 1989-11-30 | The Liposome Company, Inc. | Complexe agent actif:lipide a rapport eleve |
WO1992010166A1 (fr) * | 1990-12-11 | 1992-06-25 | Sintetica S.A. | Procede de production de liposomes a capacite accrue de piegeage des substances etrangeres a encapsuler |
WO1995026205A1 (fr) * | 1994-03-28 | 1995-10-05 | Nycomed Imaging A/S | Liposomes |
WO1995026185A1 (fr) * | 1994-03-28 | 1995-10-05 | Daiichi Pharmaceutical Co., Ltd. | Liposome a capacite de retention accrue |
EP0804925A1 (fr) * | 1994-03-28 | 1997-11-05 | Daiichi Pharmaceutical Co., Ltd. | Liposome a capacite de retention accrue |
WO1996024381A2 (fr) * | 1995-02-09 | 1996-08-15 | Schering Aktiengesellschaft | Liposomes contenant des agents de contraste pour l'imagerie relative au pool sanguin intracardiaque |
WO1996025955A1 (fr) * | 1995-02-24 | 1996-08-29 | Bracco Research S.A. | Suspensions de liposomes utilisees comme produit de contraste de visualisation du pool sanguin intracardiaque |
Non-Patent Citations (3)
Title |
---|
HENZE A ET AL: "RADIO-OPAQUE LIPOSOMES FOR THE IMPROVED VISUALISATION OF FOCAL LIVER DISEASE BY COMPUTERIZED TOMOGRAPHY", COMPUTERIZED MEDICAL IMAGING AND GRAPHICS, vol. 13, no. 6, 1989, pages 455 - 462, XP002049028 * |
KRAUSE, W. ET AL: "Liposomes in diagnostic imaging: comparison of modalities; in vivo visualization of liposomes", JOURNAL OF LIPOSOME RESEARCH, vol. 5, no. 1, 1995, pages 1 - 27, XP002063540 * |
LEANDER P.: "Liver specific contrast media for MRI and CT. Experimental studies", ACTA RADIOLOGICA SUPPLEMENTUM, vol. 36, no. supp. 396, 1995, pages 1 - 36, XP002063541 * |
Also Published As
Publication number | Publication date |
---|---|
JP2001504837A (ja) | 2001-04-10 |
WO1998023297A2 (fr) | 1998-06-04 |
AU5129398A (en) | 1998-06-22 |
EP1009445A2 (fr) | 2000-06-21 |
GB9624918D0 (en) | 1997-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA979550B (en) | Method for the preparation of methylidene malonate nanoparticles, nanoparticles which optionally contain one or more biologically active molecules, and pharmaceutical compositions containing them. | |
HK1017995A1 (en) | Compounds and compositions for delivering active agents. | |
WO1997026919A3 (fr) | Methode d'imagerie de depots amyloides | |
IL115039A (en) | Spiroazabicyclic compounds, their preparation and pharmaceutical compositions containing them | |
PL322195A1 (en) | Novel composition in the form of oil-in-water emulsion for local application | |
EP0871444A4 (fr) | Pyrroles d'aryle substitues en position 2 et 5, compositions contenant de tels composes et leurs modes d'utilisation | |
HU0500549D0 (en) | Azolo-pyridimidines, pharmaceutical compositions containing the same and use thereof | |
ZA959853B (en) | Lubricating composition including an ester - use of the composition and well fluid including the composition. | |
CA2194979A1 (fr) | Formes de medicaments solides contenant des clathrates d'hormones sexuelles steroidiennes | |
ZA972404B (en) | Detergent compositions and method of use for the delivery of fragrance precursors. | |
HK1019757A1 (en) | Synthetic polysaccharides, preparation method therefor and pharmaceutical compositions containing same. | |
IL112235A0 (en) | 8-Aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline 2,3-dione derivatives and pharmaceutical compositions containing them | |
EP0674899A3 (fr) | Composition déodorant. | |
IL113366A0 (en) | 1,5-benzodiazepine compounds, their preparation and use, and pharmaceutical compositions containing them | |
IL121969A (en) | 10,13,15-trioxatricyclo¬9.2.1.1.9.6¾-pentadecanone derivatives their preparation and pharmaceutical compositions containing these compounds | |
AU1238900A (en) | Speckle particles and compositions containing the speckle particles | |
ZA971746B (en) | Taxoids, their preparation and pharmaceutical compositions containing them. | |
WO1998023297A3 (fr) | Compositions particulaires | |
HUP0001551A3 (en) | Improved method for producing thiazolidinediones, thiazolidinediones and pharmaceutical compositions containing the same | |
EP0684038A3 (fr) | Compositions déodorentes. | |
IL116828A0 (en) | Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions | |
AU3674595A (en) | Antianemic agent containing iron and difructose | |
IL116745A0 (en) | Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions | |
IL116733A (en) | Sertraline for use as an anticancer agent compositions containing same preparation and uses thereof | |
HU9603388D0 (en) | New taxoids, preparation thereof and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 1998 524440 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09320629 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1997945974 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1997945974 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1997945974 Country of ref document: EP |